Oorsprong van het eerstegraads netwerk van Martijn Bax
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
AstraZeneca BV
1
| Subsidiary | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Martijn Bax via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
NewAmsterdam Pharma Holding BV
 NewAmsterdam Pharma Holding BV BiotechnologyHealth Technology Part of NewAmsterdam Pharma Co. NV, NewAmsterdam Pharma Holding BV is a Dutch company that engages in research and development of transformative therapies for cardio metabolic diseases. The company is based in Naarden, the Netherlands. The company was founded in 2019 by John Jacob Pieter Kastelein. Michael H. Davidson has been the CEO of the company since 2020. NewAmsterdam Pharma Holding was acquired by Frazier Lifesciences Acquisition Corp. on November 22, 2022 for $468.74 million. | Biotechnology | Corporate Officer/Principal | |
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Vrije Universiteit Amsterdam | College/University | Doctorate Degree |
Statistieken
Internationaal
| Nederland | 4 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Operationeel
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sterkste connecties
| Insiders | |
|---|---|
| Marc Ditmarsch | 4 |
- Beurs
- Insiders
- Martijn Bax
- Bedrijfsconnecties
